tide-1 analog taspoglutide in combination with metformin improvesglycemic control and lowers body weight in patients with type 2diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study. Diabetes Care 32:1237–1243 39.Shen L, Han J, Yushmanova I, Bruce S, Wilhelm K, Porter L 2009 Cardiovascular safety of exenatide BID: an integrated-analysis fromlong-term controlled clinical trials in subjects with type 2 diabetes.Diabetologia 52(Suppl 1):S298 40.Best JH, Hoogwerf BJ, Herman WH, Pelletier EM, Smith DB, Wenten M, Hussein MA 2011 Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the GLP-1 receptor ag-onist exenatide twice daily or other glucose-lowering therapies: aretrospective analysis of the LifeLink TMdatabase. Diabetes Care 34:90–95 Sign up for eTOC alerts today   to get the latest articles as soon as they are online. http://mend.endojournals.org/subscriptions/etoc.shtml